Project: Strategic Plan for the development and production of sterile oncological drugs (liquid and lyophilized vials) in Vivunt Pharma’s new pharmaceutical plant in León.

Objective: To carry out the galenic and analytical development of four sterile oncological drugs, along with their technology transfer lots and validation for registration.

This project is funded by the European Regional Development Fund (ERDF) of the European Union and the Junta de Castilla y León, through the Institute for Business Competitiveness of Castilla y León (ICE), with the aim of promoting research, technological development, and innovation.